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Apoptotic efficacy of multifaceted 
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Blassan Plackal Adimuriyil George 1, Neeraj Kumar 2,3, Heidi Abrahamse 1 & 
Suprakas Sinha Ray 2,3
Metallic nanoparticles (NPs) especially silver (Ag) NPs have shown immense potential in medical 
applications due to their distinctive physio-chemical and biological properties. This article reports the 
conjugation of Ag NPs with Rubus fairholmianus extract. The modification of Ag NPs was confirmed 
using various physico-chemical characterization techniques. The cytotoxic effect of Rubus-conjugated 
Ag NPs (RAgNPs) was studied by LDH assay and proliferation by ATP assay. The apoptotic inducing 
ability of the NPs were investigated by Annexin V/PI staining, caspase 3/7 analysis, cytochrome c 
release, intracellular ROS analysis, Hoechst staining and mitochondrial membrane potential analysis 
using flow cytometry. The expression of apoptotic proteins caspase 3, Bax and P53 were analyzed 
using ELISA and caspase 3, Bax using western blotting. Cells treated with 10 µg/mL RAgNPs showed 
an increased number of cell death by microscopic analysis compared to untreated control cells. The 
RAgNPs induced a statistically significant dose-dependent decrease in proliferation (p < 0.001 for 
5 and 10 µg/mL) and increased cytotoxicity in MCF-7 cells. A 1.83 fold increase in cytotoxicity was 
observed in cells treated with 10 µg/mL (p < 0.05) compared to the untreated cells. Nuclear damage and 
intracellular ROS production were observed upon treatment with all tested concentrations of RAgNPs 
and the highest concentrations (5 and 10 µg/mL) showed significant (p < 0.05, p < 0.01) expression of 
caspase 3, Bax and P53 proteins. The data strongly suggest that RAgNPs induces cell death in MCF-7 
cells through the mitochondrial-mediated intrinsic apoptosis pathway. The present investigation 
supports the potential of RAgNPs in anticancer drug development.
Cancer is one of the most deadly diseases with high mortality rates. It refers to a collection of diseases where cer-
tain cells the body begin to grow and multiply disorderly. Nanotechnology has shown significant promise in the 
development and delivery of drugs that can potentially contribute to overcome many limitations of current drug1. 
Nanomedicine is the use of nanotechnology in medicine and the use of nanoparticles (NPs) for the treatment of 
various diseases is one of the characteristics of nanomedicine. Recent increases in the number of different nano-
materials produced is contributing to the advancement of nanomedicine in diverse fields. Nanoparticles coated or 
conjugated with multiple functionalities are able to target the tumor site thereby allowing the early detection and 
the eradication of tumors. Many noble metal and metal oxides/sulphides NPs have been studied for oncological 
applications including anticancer activity, nanocarriers and cellular imaging1–5. Among the noble metals, silver 
(Ag) and its complexes have attracted significant attention due to its remarkable medicinal value and display 
enormous efficiency as an anticancer agent5,6. Ag NPs are one of the promising nanoproducts commonly used in 
nanomedicine because of their unique properties7,8. Ag NPs have showed antimicrobial properties against various 
bacteria, fungi, protozoa and viruses9. Recently, the anticancer effect of AgNPs has been studied against various 
cancer cells10. Ag NPs are usually smaller than 100 nm and consist of around 20–15,000 Ag atoms11. Moreover, 
Ag nanostructures can be produced as nanorods, nanotubes, nanowires, multifacets or films. At the nano-scale, 
the Ag particles exhibit different physico-chemical and biological properties compared to the regular metal12. 
Additionally, multifaceted and branched Ag NPs has garnered immense research attention in various fields but 
they are comparatively difficult to synthesize because of isotropic cubic lattices of Ag13.
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A number of approaches are employed for the synthesis of NPs; among them, biological methods are less toxic 
and eco-friendly. In the synthesis of NPs, organic molecules are used as the capping agent to aid stabilization of 
the NPs14. Among the various biosynthetic methods, the use of plant extract is desirable as they are easily accessi-
ble and contain various metabolites, which help in the reduction of silver ions, and improves the rate of synthesis. 
The need for NPs biosynthesis has increased due to the high cost associated with physical and chemical synthesis 
procedures. Moreover, the chemi-synthetic process leads to the presence of toxic chemicals on the surfaces, which 
have harmful effects in medical applications15. This problem can be overcome by green synthesis of NPs16. For this 
reason researchers are using plant extracts and phytochemicals for low-cost synthesis of NPs. With their radical 
scavenging or reducing properties, they are generally responsible for the reduction of metal compounds into their 
respective NPs. The potential of plants as biological constituents for the NPs synthesis is yet to be explored.
Considering the various limitations as well as adverse effects of current anticancer drugs, there is an urgent 
need to develop new classes of therapeutic agents with improved biocompatibility and efficacy. Rubus fairholmi-
anus, an ethnomedicinally important tropical plant from Western Ghats of India, has demonstrated excellent 
cytotoxicity towards cancer cells in our previous study17. Cytotoxic characteristics can be attributed due to pres-
ence of organic species such as phenolics and flavonoids present in the extract17. Earlier studies showed that the 
cytotoxicity of synthesized Ag NPs is associated to the involvement of the level of cellular reactive oxygen species 
(ROS) and mitochondrial membrane disruption18,19. The size of Ag NPs synthesized using the antioxidant con-
stituents from blackberry, blueberry, pomegranate, and turmeric extracts was found to be between 20–500 nm 
size, depending on the nature of extracts and method of preparation used20. However, there is a lack of detailed 
research results regarding the anticancer effects of green synthesized Ag NPs. It will be of interest to determine 
the synergistic cytotoxic effect of Ag NPs and Rubus extract on cancer cells as they could demonstrate better 
biocompatibility and enhanced therapeutic attributes. To the authors knowledge no study has been undertaken 
to determine the in vitro anti-proliferative effects of Ag NPs capped with Rubus extracts against MCF-7 breast car-
cinoma cells. Therefore, the current study was performed to modify Ag NPs with Rubus extract, and evaluate its 
anticancer potential against MCF-7 cells in vitro. The cytotoxicity, proliferation and caspase mediated apoptotic 
effects of capped Ag NPs were monitored through various in vitro analyses.
Results and Discussion
Structural characterisation of Rubus extract conjugated Ag NPs. The crystal structure and purity 
of as-prepared sample were examined by powder X-ray diffraction (XRD). All peaks in the diffraction pattern 
(Fig. 1a) were well matched with face-centred cubic phase of metallic Ag (JCPDS 04-0783)21,22. The prominent 
peaks noticed in pattern at 2θ = 38.02° (highest intensity), 44.12°, 64.33°, and 77.31° related to the (222), (200), 
(220) and (311) planes of Ag, respectively. The observed diffraction peaks are sharp, which shows the highly crys-
talline behaviour of prepared samples. The amorphous region from 12° to 30° belongs to the RFRA extracts as it 
contains various organic moieties and also indicates the crystallisation of bioorganic phase exist on the surface 
of Ag NPs.
UV-vis spectroscopy measurement (Fig. 1b) was done to investigate the reduction of metal salts into metal 
NPs in presence of RFRA extracts. The colour change from yellow to brown was observed due to the reduction 
of Ag ions to Ag NPs by active molecules of extracts. This may be attributed to the surface plasmon resonance 
(SPR) of as-prepared Ag NPs. The absorption spectrum revealed a maxima peak at 455 nm (λSPR), confirmed the 
formation of Ag NPs. Generally, the previously synthesised Ag NPs demonstrated the SPR band in the region of 
395–420 nm22,23. The red shifting of the SPR band was noticed due to in-situ conjugation of extract with Ag NPs to 
form biohybrid24. Broad absorption was noticed from 415 to 660 nm due to the localised SPR. It can be described 
by the well-known Mie resonance condition25. The lower wavelength absorption can be ascribed to bioorganic 
molecules, which are present in the RFRA extracts.
In order to determine the possible functional groups present in phytoconstituents of RFRA extracts, FTIR 
spectroscopy measurements were carried out. These functional groups play a vital role as reducing agents for 
metal salts as well as stabilisation agents for Ag NPs. The IR spectrum of RAgNPs is shown in Fig. 1c. The broad 
absorption band appears in the range of 3176–3358 cm−1 and is due to O-H and N-H stretching vibration of 
phytoconstituents (such as polyphenols and amides) of extracts. The peaks appearing at 2924, 2852 cm−1 indicate 
the presence of asymmetric and symmetric C-H groups, respectively. The weak absorption region form 2560–
2680 cm−1 is arising from thiol (S-H) stretching. The characteristics peaks at 1701 and 1599 cm−1 corresponds to 
carbonyl (C=O) and amide I (N-H) and/or C=C groups, respectively. The bands of amide II and III are found 
at 1511 and 1366 cm−1, respectively. The peaks position at 1437 cm−1 can be ascribed to alkanes C-H bending or 
COO− of carboxylate group. The peaks appearing in the region 1200–995 cm−1 are due to overlapping of C-O, 
C-N, C-O-C and C-O-P stretching modes. Furthermore, the absorption bands that appear below 1000 cm−1 are 
possibly attributed to sp2 C-H bending of alkene and aromatic regions of phytoconstituents. Thus, FTIR shows 
the possibility of flavanones, protein, amino acids, polyphenols, and cellulose molecules in the RFRA extracts, 
which are responsible for bio-reduction and stability to Ag NPs23,26. Coating of RFRA extracts enhances biolog-
ical characteristics as well as biocompatibility with stealth nature as evident from in vitro cytotoxicity behaviour.
Figure 1d demonstrates the room temperature photoluminescence (PL) emission spectrum of RAgNPs with 
excitation wavelength (λex) of 250 nm. PL emission peak positions of Ag NPs were noticed previously over a 
range from 320 to 540 nm27,28. A well-defined strong peak was observed in the PL spectra at 498 nm for Ag NPs. 
The high photoluminescent intensity probably obtained due to enhancement of electron density by coating of 
phytoconstituents on Ag NPs. The electron density plays a major role in photoluminescence emission28. The 
excitation minimum was observed around at 467 nm, which is close to the SPR obtained in UV-vis spectroscopy 
measurements (Fig. 1b). It showed that the observed PL is mainly acquired from the single-electron excitations 
between discrete Ag energy levels rather than the SPR. The luminescence regions from 468 to 300 nm can possibly 
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be attributed to ligand-metal charge transfer (LMCT) and plasmon mediated energy transfer between Ag NPs 
and phytoconstituents of extracts29.
Morphology of as-prepared Ag NPs was investigated by SEM and TEM. As shown in parts (a) to (c) of Fig. 2, 
RAgNPs have shown random shapes such as nanorods, spherical, ellipsoidal, etc. It is noticeable that these NPs 
are completely covered by Rubus extract. The size of as-prepared NPs was less than 200 nm. To check out the 
composition of RAgNPs, EDX study was carried out and result showed the presence of C, Ag, O, and S elements 
(Fig. 2d). Ag NPs are uniformly distributed throughout the sample (as shown in EDX map images Fig. 2e). Extra 
elements like C, O, and S were appeared due to the presence of residues of the extract on the surface of NPs.
Furthermore, to investigate the detailed morphological features of prepared RAgNPs, TEM study was con-
ducted and images are shown in Fig. 3a–f. Similar to SEM results, the surface of Ag NPs is covered by organic 
layer (Rubus extract), which further confirm the modification of NPs (Fig. 3a). Various morphologies of RAgNPs 
were observed including truncated decahedral particles, twinned particles, nanorods, cuboctahedron, truncated 
triangular nanoplates (Fig. 3b,c). The size of RAgNPs varied from ~30–150 nm with different shapes from spher-
ical to nanorods. The appearance of various shapes and morphologies can be attributed to capping and stabilis-
ing behaviour of different functional groups such as carbonyl acids (-COOH), carboxylate (-COOR), amines 
(-NH2), amides (-CONH2), mercapto (-SH) and hydroxyls (-OH) of the Rubus extract4,15,17,30,31. Similar Ag NP 
morphologies were reported in previous literature32,33. HRTEM of selected RAgNPs were examined and images 
are shown in Fig. 3d,e. Figure 3d showed the icosahedral particle with different lattice fringes that are orientated 
in different directions, confirm the multifaceted characteristics of as-prepared Ag NPs. In Fig. 3e, it can clearly 
be seen the lattice fringes at the edge of Ag nanorods, the crystal lattice space was 0.237 nm, which belong to the 
(111) plane of cubic Ag. It can be seen that all NPs have been effectively coated with Rubus extract (with approx-
imately 4.7 nm thickness). Representative reaction of RAgNPs formation has shown in Fig. 4. Moreover, SAED 
pattern of RAgNPs demonstrated the polycrystalline behaviour of as-prepared sample with clear visible spots 
corresponding to the main reflection lattice planes of (111), (200), (220), and (311), as similar to cubic Ag XRD 
pattern (Fig. 3f).
Zeta (ζ) potential of as-prepared RAgNPs dispersion in water was found to be −24.5 mV at room temper-
ature (Fig. S1). It indicated that the dispersion has excellent stability at neutral conditions. It also showed that 
as-prepared NPs were stabilised by electrostatic repulsion and steric hindrance of organic moieties of Rubus 
extract.
Morphology, proliferation and cytotoxicity. Morphological variations in cells following the 24 h 
RAgNPs treatment were compared with the control cells (Fig. 5). The pre-treated cells presented with an irregular 
shape and the numbers of dead cells in the treated groups were found to be increased. Total loss of membrane 
Figure 1. The XRD pattern (a), UV-vis spectrum (b), FTIR spectrum (c) and photoluminescence (PL) emission 
spectrum of RAgNPs (d).
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integrity and detachment from the culture plate were observed in the cells treated with RAgNPs. Compared to 
2.5 and 5 µg/mL treated cells 10 µg/mL treated cells were more toxic showing a higher incidence of dead cells. The 
most identifiable morphological features of apoptosis were observed in RAgNPs treated MCF-7 cells.
Uncontrolled cell division is a primary contributor to the progression of cancer. The energy level in MCF-7 
cells remained higher, which was notable from the increased ATP level in untreated cells. Treatment of MCF-7 
cells with RAgNPs caused a decrease in the intracellular ATP, which shows decreased proliferation rates. We con-
firmed that the proliferation of MCF-7 cells was inhibited in a concentration-dependent manner after exposure to 
RAgNPs (2.5, 5 and 10 µg/mL) (Fig. 5e). RAgNPs at 5 and 10 µg/mL showed significant (p < 0.001) antiprolifera-
tive activities on MCF-7 cell compared to 2.5 µg/mL (p < 0.05). However, all the doses were significant in reducing 
the cellular proliferation compared with control cells.
Similar effects were also found when the LDH assay was performed to check the cytotoxic effects of RAgNPs 
on MCF-7 cells. The LDH assay was used to measure the cellular membrane integrity following treatment with 
RAgNPs. The MCF-7 cell membrane damage was measured by the release of LDH to the culture medium. The 
untreated cells displayed low levels of LDH release related to the treated cells. A significant (p < 0.05) increase in 
toxicity was noticed at higher concentrations (5 and 10 µg/mL) of RAgNPs (Fig. 5f). A 1.83 fold increase in cyto-
toxicity was observed in MCF-7 cells when treated with 10 µg/mL compared to the 5 and 2.5 µg/mL of RAgNPs 
(1.44 and 1.04). Thus, our results suggest that RAgNPs were able to decrease the breast cancer cells while increas-
ing the cytotoxicity after 24 h treatment.
Figure 2. (a–c) SEM images of RAgNPs, (d) represents the EDX map spectrum and (e) overlapped EDX map 
followed by separate map images.
www.nature.com/scientificreports/
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AgNPs synthesised from various plant extracts have shown to induce cytotoxicity in MCF-7 cells and possess 
anticancer activities. Morphological features such as loss of membrane integrity, cytoplasmic condensation, and 
cell clumping, were observed in MCF-7 cells treated with AgNPs18,19,34,35.
Apoptotic analysis. Apoptosis plays a vital role in the homeostasis and several morphological and bio-
chemical changes in cells characterize this process. The RAgNPs statistically significantly (p < 0.001) induced 
cell death in a dose-dependent manner after 24 h treatment, the Annexin V/PI staining determined the popu-
lation of apoptotic and non-apoptotic population of cells. The results of staining (Fig. 6) displayed a substantial 
increased uptake of Annexin V by an increased cell population percentage in the lower and upper right quad-
rants in the pre-treated groups. RAgNPs significantly (p < 0.001) induced early cell apoptosis (Annexin V +/PI−) 
(9.35 ± 0.52, 10.38 ± 1.83 and 15.83 ± 1.29%) and late apoptosis (Annexin V +/PI+) (14.78 ± 0.53, 15.88 ± 1.41 
and 13.65 ± 1.44%) in MCF-7 cells at 2.5, 5 and 10 µg/mL concentrations, indicative of apoptotic cell death. In 
contrast, the early, late apoptotic and necrotic/dead cell percentages (Annexin V−/PI+) (1.23 ± 0.33, 0.60 ± 0.29 
and 0.33 ± 0.09) in untreated cells were found to be very low compared to RAgNPs treatments, while the percent-
ages of viable cells (Annexin V−/PI−) decreased upon the treatment with NPs.
Upregulation of caspases, apoptotic mediators, were observed after exposure of MCF-7 to the RAgNPs. The 
activation of caspases (3 and 7) were measured in cells treated with three different doses of RAgNPs after 24 h 
Figure 3. TEM images of RAgNPs: (a) various morphologies of Ag NPs, (b) truncated decahedral particles 
(Ci) twinned particle, (Cii) nanorods, (Ciii) cuboctahedron, (Civ) truncated triangular nanoplates, (d) HRTEM 
of icosahedral particle with fringes orientation directions, (e) HRTEM of nanorods and represent also coating 
surfaces (f) SAED image of RAgNPs. Right side shows the artistic representation of morphologies viz. truncated 
decahedral particles, nanorods and cuboctahedron (from top to down).
www.nature.com/scientificreports/
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incubation. The levels of caspase expression were compared with the untreated cells arbitrarily set to 1.0. The 
results revealed that RAgNPs increased caspase 3/7 upregulation at various doses while 10 µg/mL showed the 
highest caspase 3/7 activity (Fig. 7a). At 10 μg/mL of RAgNPs, caspase 3/7 activity extended to a maximum of 
1.18 fold increase after 24 h incubation (p < 0.001). Similar results were observed at 5 μg/mL (1.09 fold increase) 
(p < 0.01). Even though a similar trend was observed in all concentrations, higher dose showed a significant 
(p < 0.001) increase in caspase 3/7 activity.
Cytochrome c release is an important event in the execution phase of cell damage via the intrinsic apoptotic 
pathway. A difference in various proapoptotic and apoptotic proteins in cells lead to damage of the mitochon-
drial membrane, resulting in discharge of cytochrome c and followed by caspase 3 activation. The release of 
cytochrome c was determined after 24 h RAgNPs treatment. The ELISA results of cytochrome c release revealed 
that in the control, the cells were unable to initiate such a damaging event and low cytochrome c release was 
observed (Fig. 7b). All doses of RAgNPs treated cells showed significant (p < 0.001) release of cytochrome c 
compared to control cells; the fold increase observed were 4.11, 5.5 and 6.4 for 2.5, 5 and 10 µg/mL, respectively.
To further confirm that RAgNPs induced apoptosis, mitochondrial membrane potential or mitochondrial 
destabilization was measured in MCF-7 cells after the treatment with RAgNPs. Figure 8 shows that RAgNPs 
induced significant damage to mitochondria after 24 h incubation. The percentages of polarized and depolarized 
membrane potential in each group was determined and compared to the respective percentage of the control 
cells. After 24 h of incubation with JC-1 stain, no change in membrane potential was detected in control cells. 
However, changes in both polarized and depolarized cell populations were noticed in RAgNPs treated cells. The 
treated cells increased the depolarized mitochondrial membrane and decreased the polarized membranes. All 
the tested concentrations of RAgNPs (2.5, 5 and 10 μg/mL) significantly (p < 0.001) increased the depolarized 
mitochondrial membrane (24.95 ± 2.25, 27.08 ± 2.01, 32.67 ± 2.27%) and decreased the polarized mitochondrial 
membrane (75.05 ± 2.25, 72.93 ± 2.01 and 67.33 ± 2.27%).
In order to recognize the cell death pathway induced by RAgNPs, we examined the activation of two specific 
effector caspases (caspases 3 and 7), release of cytochrome c and the changes in mitochondrial membrane poten-
tial. The Annexin V/PI staining showed the induction apoptosis by the increased percentages of apoptotic cells in 
the treated groups. The increased cytotoxicity and decreased proliferation in cells is due to various factors such as 
size of the NPs, Ag content and capping agents. Small NPs exhibited higher toxicity due to the enhanced cellular 
uptake and large surface area for interaction with biomolecule35,36. Apoptosis and necrosis, the most preferred 
cell death mechanisms37 investigated upon AgNPs exposure. Annexin-V FITC was used as an apoptotic marker 
while PI used to detect membrane integrity to identify necrosis38. Our results clearly showed the increased early 
and late apoptotic cells percentage upon treatment, which encourages us to trace the apoptotic signalling path-
way. Apoptosis is related with the ROS generation and JNK activation39, mitochondrial depolarisation40, caspase 
upregulation41, and calcium overload42 or by death-inducing signals43.
Ag NPs perform well as cancer therapeutics because they can disrupt the mitochondrial respiratory chain, 
which induces the ROS generation, DNA damage and ATP synthesis18. Upon treatment with AgNPs or cisplatin, 
MCF-7 cells showed decreased Bcl-2 expression and increased Bax expression, representing the mitochondrial 
connection in cell death44. Mitochondria function as critical centres of signalling; various apoptotic regulators 
can compromise the mitochondrial integrity. The ROS generation by AgNPs may also require mitochondrial 
involvement, which initiates the intrinsic apoptotic pathway45,46. Our results are in agreement with this statement; 
Figure 4. Representative reaction for RAgNPs formation and schematic for nanoparticle induced cancer cell 
apoptosis.
www.nature.com/scientificreports/
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the treatment of MCF-7 cells with Ag NPs induced cytochrome c release and eventually changed the mitochon-
drial membrane potential. Mitochondria are known to be involved in programmed cell death; we investigated the 
changes in mitochondrial membrane potential in terms of JC-1 fluorochrome. In our study, the strong dissipation 
in mitochondrial membrane potential in the RAgNPs exposed MCF-7 cell line suggests a possible dysfunction of 
Figure 5. Morphological changes in MCF-7 cells after RAgNPs treatment. There were no significant visible 
differences in control (a) and 2.5 µg/mL treated groups (b), the cells did not show any cellular shrinkage and 
apoptotic bodies after the treatment. However, more dead cells were observed at higher concentrations (5 
and 10 µg/mL). The treated cells showed loss of intact membrane, loss of contact with neighbouring cells, 
condensed, detached from the culture plate showed the features of apoptotic cells. The ATP luminescent cell 
proliferation assay (e) was used to determine MCF-7 cell proliferation after the treatment with RAgNPs. Control 
cells showed an increased ATP level, whereas a dose dependent significant (***p < 0.001 and **p < 0.05) 
decrease in ATP level was observed in experimental groups. The Lactate Dehydrogenase (LDH) cytotoxicity 
test (f) showed a significant increase in cytotoxicity of cells after the 24 h treatment with RAgNPs compared to 
control cells. The significant differences between treated and controls groups are shown as *p < 0.05.
Figure 6. Annexin V FITC/PI staining was used to assess the mode of cell death. RAgNPs treated MCF-7 cells 
showed an increased percentage of apoptotic population after 24 h incubation. The population of early and 
late apoptotic cells percentage in the control group found to be lower and the live cells percentage was higher 
in control cells compared with experimental groups. A significant decrease (***p < 0.001) in the live cells and 
increase in the early, late apoptosis and dead cells percentage were observed in treated MCF-7 cells.
www.nature.com/scientificreports/
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cellular mitochondrial membrane after treatment. The loss of mitochondrial membrane potential might be the 
reason for the involvement of apoptosis in the AgNPs treated cells47. Small changes in particle size and functional 
groups on the surface of NPs affect the cell death mechanisms. Additionally, these factors may also have signifi-
cant effect on NPs and membrane interaction, NP internalization and degradation within cells.
Basically, Ag NPs cytotoxicity occurred due to their chemical transformation of neutral silver (Ag°) to Ag+, 
Ag-O-, Ag-S-, which lead to ROS production by chain effect (Fig. 4). The dynamically chemical and biological 
changes were observed on ROS production. The generation of ROS was evaluated after exposure to various concen-
trations of RAgNPs. An increase in the intracellular ROS levels was observed, as shown in Fig. 9. H2O2 treated cells 
were kept as positive control. The increased ROS production observed in the H2O2, 2.5, 5 and 10 µg/mL of RAgNPs 
treated groups compared with the control. These results reflects that RAgNPs are capable of inducing cytosolic 
oxidative stress and thereby promote cell death. Similarly, the groups treated with RAgNPs (2.5, 5 and 10 µg/mL) 
showed a significant nuclear damage in Hoechst satin. The Hoechst nuclear stain was used to measure the level of 
DNA damage. The control cells showed dense spherical homogenously stained nuclei, whereas the cells treated with 
RAgNPs showed irregular nuclear shape, scattered nuclear granules suggestive of nuclear fragmentation (Fig. S2).
The accumulation of ROS disturb the redox control of cell cycle progression via phosphorylation and ubiq-
uitination of cell cycle regulatory proteins such as cyclins, Cdks and Cdk inhibitors, leading to aberrant cell pro-
liferation and apoptosis48. Our results revealed that the release of cytochrome c and caspase 3/7 activity were up 
Figure 7. Caspase 3/7 activity (a) was determined as a function of caspase dependent apoptosis in cells after 
the 24 h treatment. There was a highly significant (p < 0.001) increase in caspase 3/7 activity after 10 µg/mL 
RAgNPs treatments compared to 2.5 and 5 µg/mLconcentrations and control cells. Cytochrome c release (b) 
is an important measure of cellular damage. RAgNPs treated cells showed significant (***p < 0.001) release of 
cytochrome c compared to control cells. The significant differences between treated and controls groups are 
shown as ***p < 0.001.
Figure 8. Evaluation of mitochondrial membrane potential using the flow cytometric analysis of JC-1 
fluorometric stain. Percentage of polarized (black) and depolarized (grey) mitochondrial membrane potential were 
determined and compared to the percentage of the corresponding mitochondrial membrane potential of untreated 
cells. Only the PDT-treated cells showed a change in mitochondrial membrane potential (***p < 0.001).
www.nature.com/scientificreports/
9SCIenTIfIC RepoRts |  (2018) 8:14368  | DOI:10.1038/s41598-018-32480-5
regulated in a ROS-dependent manner in MCF-7 cells, the nuclear degeneration observed by Hoechst stain also 
supports the results (Fig. S2). The toxicity of RAgNPs on WS1 fibroblast cells (normal) were tested and the results 
are shown in Fig. S3. The RAgNPs are not cytotoxic to the normal cells compared to the cancer cells. The mor-
phological evaluation of WS1 cells after the 24 h treatment did not show more dead cells, which also no signs 
of cytotoxicity in LDH assay and did not influence on the proliferation in ATP assay, which indicating the less 
toxicity. Mitochondrial and cellular reactive oxygen species (ROS) play important roles in both physiological and 
pathological processes. Different ROS, such as superoxide, hydrogen peroxide, and peroxynitrite, stimulate distinct 
cell-signalling pathways and lead to diverse outcomes depending on their amount and subcellular localization49.
To investigate the effect of RAgNPs in inducing the intrinsic apoptotic pathway we examined the expression 
of caspase 3, Bax by western blotting (Fig. 10a) and caspase 3, Bax and P53 expression by ELISA (Fig. 10b–d). 
In cancer cells the proapoptotic proteins level will be low compared with apoptotic cells. In our experiments, 
the proapoptotic proteins such as P53, caspase 3 and Bax levels were high in treated groups than control cells. 
The RAgNPs at 5 and 10 µg/mL concentrations showed significant (p < 0.05 and p < 0.01) expression of all three 
proteins tested. Upon treatment active P53, caspase 3 and Bax highly expressed in nucleus. The activation of 
these proteins leads to mitochondrial permeability; these results were supported by the mitochondrial membrane 
potential assay and cytochrome c release.
Caspase 3, play a central role in the execution of apoptosis by activating the cleavage of PARP. The sequence at 
which caspase 3 cleaves PARP is very well conserved in the PARP protein from very distant species, indicating the 
potential importance of PARP cleavage in apoptosis50,51. In the present study, we have examined the expression of 
caspase 3 and subsequent apoptosis in MCF-7 cells treated with RAgNPs. PARP is cleaved by caspase-3 early during 
apoptosis in many different cell lines. P53 is a multifunctional tumor suppressor that regulates DNA repair, cell 
cycle arrest, apoptosis, cell survival as well as oxidative stress. P53 responds to a wide range of cell death stimuli, 
which can induce apoptosis by activating gene expression, or by permeabilizing mitochondria. P53 accumulates 
in the nucleus and control the expression of proapoptotic member, Bax52. P53 can translocate to mitochondria, 
interact with the antiapoptotic Bcl-2 proteins, neutralise them and cause apoptosis53. The present study showed the 
expression of P53 in MCF-7 cells when treated with RAgNPs. P53 directly activate the proapoptotic Bcl-2 protein 
Bax to permeabilize mitochondria and engage in apoptosis. The Bcl-2 family proapoptotic proteins, Bax and Bak, 
are major regulators and effectors of mitochondrial outer membrane permeabilization (MOMP). Whereas the antia-
poptotic members suppress MOMP by inhibiting the activation of Bax/Bak. The proapoptotic proteins, considered 
the stress signals, promote MOMP by direct or indirect activation of Bax/Bak. Once activated, both Bax and Bak 
form homo-oligomers on the outer mitochondrial membrane, and generate membrane pores, which further allow 
the release of apoptogenic proteins cytochrome c from the intermembrane space, leading to the formation of apop-
tosome and subsequent effector caspase activation thereby the execution of mitochondrial intrinsic apoptosis54,55. 
Our results showed the significant release of cytochrome c and mitochondrial membrane permeabilization, which is 
directly, linked with the expression of the proapoptotic proteins Bax and the expression of caspase 3 and P53 apop-
totic mediators in western blotting and ELISA experiments. Therefore, the induction of P53 regulated apoptosis in 
MFC-7 breast cancer cells upon RAgNPs treatment is a major target for cancer therapy.
These findings suggest that RAgNPs significantly induced mitochondria mediated caspase dependant apop-
tosis. The molecular mechanism of RAgNPs mediated up-regulation of caspases should be investigated further.
Figure 9. Effect of RAgNPs on ROS production; the green signals showing increased production of ROS upon 
treatment, in the control (a) slide ROS production is less compared with the RAgNPs treated groups (c–e); H2O2 
treated group served as the positive control. The quantitative measurement of the ROS (b) showed that there is 
significant increase in ROS in RAgNPs treated groups in a dose dependent manner.
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Conclusion
We demonstrated biological green synthesis of AgNPs using Rubus extract. The successful formation of Rubus extract 
layers on the surface of Ag NPs was confirmed by SEM, TEM, FTIR, and XRD measurements. The synthesised 
RAgNPs showed antiproliferative effects on MCF-7 breast cancer cells in a dose dependent manner. Interestingly, it 
was observed that anticancer activity of RAgNPs is strongly associated with the induction of apoptosis by mitochon-
drial pathway. Apoptosis was significantly higher in the RAgNPs treated cells with increased caspase 3/7 activity, 
cytochrome c release (p < 0.001) and increased percentages of early and late apoptotic cells (p < 0.001). All doses of 
RAgNPs (2.5, 5 and 10 μg/mL) significantly (p < 0.001) increased the depolarized mitochondrial membrane (24.95, 
27.08 and 32.67%) and decreased the polarized mitochondrial membrane (75.05, 72.93 and 67.33%) due to its cyto-
toxic behaviour. Our results showed significant increases in cytotoxicity, caspase 3/7 activity, cytochrome c release, 
depolarized mitochondrial membrane potential, nuclear damage, ROS production and a decrease in cellular pro-
liferation, which ultimately support the high uptake and anticancer activity of RAgNPs. The highest concentrations 
of RAgNPs showed significant (p < 0.05 and p < 0.01) expression of caspase 3, Bax and P53 proteins in ELISA and 
western blotting experiments. We have shown mechanistically AgNPs activates the intrinsic apoptotic pathway in 
MCF-7 breast cancer cells. Further studies will be conducted to determine the cytotoxic potential of other medically 
sound extracts and available cancer drugs with Ag NPs on cancer cells.
Methods
Materials. All required chemicals were procured from Sigma-Aldrich, South Africa and used directly without 
any additional purification.
Preparation of Rubus fairholmianus root acetone extracts (RFRA). R. fairholmianus was collected 
from India and authenticated (voucher specimen no: BSI/SRC/ 5/23/2010-11/Tech.1657) by Botanical Survey of 
India. The root, stem and leaves were extracted in Soxhlet using acetone and the dried extract dissolved in 0.5% 
DMSO for further analysis. The preliminary screening showed that root possessed high content of phytochemi-
cals and higher radical scavenging property.
Synthesis of Rubus extract conjugated Ag nanoparticles. The Rubus extract conjugated Ag NPs 
(RAgNPs) were synthesized by R. fairholmianus root acetone extracts (RFRA) mediated bio-reduction of silver 
nitrate. Briefly, 15 mM of silver nitrate salt (AgNO3, purity >99%, purchased from Sigma-Aldrich, South Africa) 
was dissolved in 200 mL of deionized water using magnetic stirring at room temperature. Then, 0.6 g of prepared 
RFRA was introduced into the solution. The RFRA extract capped the silver ions and reduced them into Ag NPs 
within 5–6 min. The fast colour change of reaction solution from yellow to brown exhibited the formation of Ag 
Figure 10. Effect of RAgNPs on apoptotic protein expression of caspase 3, Bax by western blotting (a) (L1-
Control; L2- RAgNPs-2.5 µg/mL; L3- RAgNPs-5 µg/mL; L4- RAgNPs- 10 µg/mL). (b–d) shows the effect of 
RAgNPs on caspase 3, Bax and P53 expression by ELISA. The results showed that the proapoptotic proteins 
such as P53, caspase 3 and Bax levels were significantly increased in RAgNPs treated groups than control cells.
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NPs. Further, the reaction mixture was left stirring for 6 h at 30 °C. After completion, reaction mixture was centri-
fuged (7000 rpm) multiple times using deionized water and ethanol to remove excess extracts.
Materials Characterizations. The ultraviolet-visible (UV-Vis) spectrum of as-prepared sample was car-
ried out using Shimadzu UV-2450. Transmission Electron Microscope (TEM, 200 kV, JEOL-JEM-2100, Japan) 
was used to characterise internal morphologies of RAgNPs. A diluted suspension in ethanol was prepared and 
the cupper grid was twice dipped in this suspension. Sample grid was properly dried before measurement. 
Scanning Electron Microscopy (SEM) images were received using TESCAN, VEGA SEM under a 20 kV elec-
tron acceleration voltage coupled with an energy dispersive X-ray spectrum (EDS). The powder XRD pattern 
was recorded using Philips PAN Analytical X’Pert X-ray diffractometer equipped with a Ni-filtered Cu Kα 
radiation source of the 0.15418 nm. The instrument was operated at 40 kV and 45 mA with a scanning rate 
of 1°/min for scan angles of 5 to 90°. The photoluminescence spectrum at room temperature was acquired 
using Perkin Elmer (LS 45 Fluorescence Spectrometer, 230 V). Attenuated Total Reflectance-Fourier Transform 
Infrared Spectroscopy (ATR-FTIR) measurement was carried out using Perkin Elmer Spectrum 100 FTIR 
spectrophotometer.
Cell culture. Human breast cancer cells MCF-7 (ATCC HTB-22) were used for the in vitro studies. The cells 
were cultured in Dulbecco’s Modified Eagle Medium (DMEM) media with 10% heat inactivated Fetal Bovine 
Serum (FBS) (FBS; Gibco 306.00301). The medium was supplemented with1% penicillin/streptomycin (PAA 
Laboratories GmbH, P11-010) and 1 µg/mL Amphotericin B (PAA Laboratories GmbH, P11-001).
Human skin fibroblast monolayer cultures (WS1-ATCC CRL1502) were grown in Eagle’s minimal essential 
medium (Invitrogen 32360–026) that was modified to contain 2 mM L-glutamine (Gibco, 25030), 1 mM sodium 
pyruvate (Gibco, 11360), 0.1 mM nonessential amino acids (Gibco, 11140), 1% amphotericin-B (Gibco, 104813), 
1% penicillin–streptomycin (Gibco, 15140) and 10% v/v foetal bovine serum (FBS; Gibco, 306.00301).
Cells were maintained in a CO2 incubator (37 °C, 5% CO2 and 80% humidity). Cells were washed with Hank’s 
Balanced Salt Solution (HBSS, Invitrogen, 10–543 F) when it became confluent and detached with TryplExpress 
(Gibco, 12604) and subcultured. Cells were seeded at a concentration of 5 × 105 cells/plate in 3.5 cm2 diameter 
culture plate.
Morphological evaluation. Analysis of cellular morphological changes in cells after the treatments with 
RAgNPs was important for the preliminary evaluation of cytotoxic effects. After 24 h of incubation with dif-
ferent concentrations of RAgNPs (2.5, 5 and10 µg/mL), the cells were rinsed with HBSS and replenished with 
fresh medium, then the morphological changes were noticed using Wirsam, Olympus CKX 41 inverted light 
microscope.
Proliferation and cytotoxicity. CellTiter-Glo1 luminescent assay (Promega, G7571, Anatech Analytical 
Technology, South Africa) quantifies the ATP levels in metabolically active cells. Briefly, 50 µl of ATP reagent 
and cell suspension was incubated at room temperature for 10 min in dark and the luminescence was measured 
using 1420 Multilabel Counter Victor3 (Perkin-Elmer, Separation Scientific). The Cyto-Tox96 X assay (Anatech, 
Promega G 400) was used to evaluate the cytotoxic activity of C1 and C2 on MCF-7 cells. The membrane integrity 
was assessed by quantifying the Lactate Dehydrogenase (LDH) released to the media following the pre-treatment 
with RAgNPs. The LDH reagent and culture medium (50 µl each) were mixed and incubated in dark at room 
temperature for 30 min and colorimetric compound was read at 490 nm (Perkin-Elmer, VICTOR3™). The more 
LDH released to the culture medium the more cytotoxic. The proliferation and cytotoxicity were evaluated based 
on a comparison with untreated cells and the IC50 values were calculated.
Annexin V/PI double staining. The Annexin V-fluorescein isothiocyanate (FITC) apoptosis detection kit 
(Becton Dickinson, 556570, Scientific Group, South Africa) was used to distinguish the population of apop-
totic and non-apoptotic cells. The cell suspension (1 × 106/mL) (100 µl) was stained with 5 µl of Annexin V and 
propidium iodide (PI), vortexed and incubated for 10 min at room temperature in dark. After the staining, flow 
cytometry was performed using Fluorescence Activated Cell Sorting (FACS) Aria flow cytometer (BD Bioscience) 
to quantify the population of apoptotic and non-apoptotic cells.
Caspase 3/7 activities and cytochrome c release. The downstream executioner enzymes caspase 
3/7 activities was evaluated using the Caspase-Glo 3/7 luminescent kit (Promega G8091, Whitehead Scientific, 
Bracken fell, South Africa) for the determination of caspase activity. Equal volume (50 µl) of RAgNPs pre-treated 
cells and caspase reagent was seeded in 96-well luminous plate (Scientific Group Adcock Ingram, Midrand, South 
Africa BD354651), incubated for 3 h at room temperature. The cleavage of substrate by caspases was measured by 
generated luminescent signal and was measured using Victor3 (Perkin-Elmer, Separation Scientific).
An apoptotogenic enzyme, cytochrome c is vital for apoptotic events. An Enzyme-linked immunosorbent 
assay (ELISA) (human cytochrome c Platinum ELISA kit) was used to quantify the cytochrome c in cytosol. 
Briefly, the resuspended cells were lysed and the lysate was spun and a 50-fold dilution of the supernatant was 
done with 1 x assay buffer. Lysate was further diluted (1:2); a volume of 100 μl sample was added to all wells 
containing 1x assay buffer. Fifty microliters of biotin-conjugated anti-human cytochrome c antibody was added 
and incubated for 2 h at room temperature. Thereafter, the plate was washed three times with 400 μl wash buffer 
and Streptavidin-HRP secondary antibody (100 μl) was added and incubated for 1 h. Tetramethyl-benzidine 
(TMB) (100 μl) substrate was added after washing and incubated for 10 min. Finally, the reaction was stopped and 
absorbance was measured at 450 nm using the Victor3 (Perkin-Elmer, Separation Scientific).
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Mitochondrial membrane potential analysis. The evaluation of mitochondrial membrane potential 
(ΔΨm) variations is an indirect measure of intrinsic apoptosis pathway. ΔΨm were analysed using BDTM Mito 
Screen flow cytometry mitochondrial membrane potential detection kit (Cat No. 551302). 1st J-aggregate-forming 
cationic dye (JC-1), is a fluorochrome used to evaluate the ΔΨm. Viable cells with polarized ΔΨm able to take 
up the JC-1 stain to form mitochondrial JC-aggregates with a red spectral shift and fluorescence. Damaged cells 
with depolarized mitochondria cannot take up JC-1 stains, do not fluoresce and JC-1 remains in the cytoplasm 
as its monomer. Briefly, the cells were resuspended in HBSS (1 mL) and spun at 1200 rpm for 5 min at 4 °C. The 
cells were dissolved in JC-1 working solution (0.5 mL). The mixture was incubated at 37 °C in a CO2 incubator 
for 15 min, followed by washing (twice) with 1 mL of 1 x assay buffer and centrifuged at 1200 rpm. Finally, the 
cells were dissolved in 0.5 mL of 1 x assay buffer, vortexed and analysed using Fluorescence Activated Cell Sorting 
(FACS) Aria flow cytometer (BD Biosciences).
Reactive Oxygen Species (ROS) assay and Hoechst staining. The cellular ROS produced was meas-
ured by Dichlorodihydrofluorescein diacetate (DCFH-DA) assay. Briefly, the cells were cultured in 3.4 cm2 diam-
eter culture dishes over sterile cover slips for 20 h and were treated with 100 μM DCFH-DA for 30 min in dark. 
Followed by DCFH-DA reaction, the cells were treated with RAgNPs for 12 h. The nuclear stain, 4′−6-Diamidino-
2-phenylindole (DAPI, Invitrogen, D1306) (1 μg/mL) were added and incubated for 10 min in dark. Following 
the completion of the DCFH-DA and DAPI reaction, the cells were washed thrice with PBS (2 mL). The cover 
slips were fixed on clean glass slides using mounting media (Propyl Gallate, Fluka, Sigma-Aldrich, 02370) and 
were sealed. The slides were examined using the Carl Zeiss Axio Observer Z1. The following filters were used for 
fluorescent compounds: 358Ex/461Em for DAPI and 494Ex/518Emfor DCFH-DA. For the quantitative analysis 
of ROS generation, MCF-7 cells were grown in 96 well tissue-culture plates until 80% confluent and treated with 
various concentrations of RAgNPs. Reactive oxygen species present inside cells were measured using dichloro-
fluorescein (DCF) fluorescence. 1 µM Dichlorodihydrofluorescein diacetate (DCFH-DA) was added MCf-7 and 
incubated for 30 min. The fluorescence of oxidized DCFH-DA was read at Ex540 nm/Em572 nm after 1 h using a 
Victor3 (Perkin-Elmer, Separation Scientific).
The nuclear damage induced by RAgNPs was observed by Hoechst staining. Cells were cultured in 3.4 cm2 
diameter culture dishes over sterile cover slips for 20 h in a culture dish and treated with various concentrations 
of RAgNPs. After 24 h incubation, cells were stained with 1 μg/mL Hoechst stain (Hoechst 33258, H21491) for 
15 min. Thereafter, the cells were rinsed with PBS and the blue fluorescent signal was examined using the Carl 
Zeiss Axio Observer Z1 with the filter set of 352Ex/461Em wavelength.
Western blot analysis. The concentration of proteins in cell lysates was assessed using BCA Protein Assay 
Reagent (Thermo Fisher Scientific, Rockford, IL, USA). Depending on protein concentration, cell lysates were 
diluted in RIPA buffer to the gel-loading concentration of proteins (2.5 μg/μl), mixed with equal volume of sam-
ple buffer (0.125 M Tris/HCl pH 6.8, 10% glycerol, 4% SDS, 0.25 M DTT) and heated for 5–7 min at 110 °C. 
Protein samples were separated using a protein electrophoresis (Bio-Rad, Hercules, CA). The proteins separated 
by SDS-PAGE were transferred to PVDF membrane Immun-Blot (Biorad Cat:162–0177) for 3 h at 0.25 A, using 
a Semi Dry blotter (Sigma-B2529). The membrane was blocked with 5% BSA in TBS for 15–20 min and incu-
bated with respective primary antibody (Caspase 3- mouse monoclonal antibody, Cat# SC-7272, Santa Cruz 
biotechnology; Bax- mouse monoclonal antibody, Cat# 336400, Life technologies; GAPDH- mouse monoclonal 
antibody, Cat# MA5-15738, Invitrogen) at 4 °C overnight. After the incubation, the membrane was washed three 
times (5–10 min) with TBS containing 0.1% Tween-20 and incubated for 2 h with the horseradish peroxidase 
conjugated secondary antibody (Goat anti-mouse HRP, Cat# SC-2005, Santa Cruz Biotechnology). Afterwards, 
the membrane was washed with TBS and the chromogenic signal was detected by adding the colour-developing 
reagent (1% DAB 250 µl + 0.3% H2O2 250 µl added to 5 mL of PBS), kept in dark for 5 min, and developed bands 
were scanned.
Enzyme Linked Immunosorbent Assay (ELISA). We used cell based ELISA, to analyse the expression 
of caspase 3, Bax and P53 in cultured cells. After 24 h treatment, cells were detached using TrypLETM (Gibco, 
12563-029, Life Technologies) and 3 × 104 cells were seeded into a 96-well flat-bottomed microplate (Corning®, 
Costar® 3596). Cells were allowed to adhere in a total volume of 100 μL media and were fixed using 8% paraform-
aldehyde (100 μL). After 15 min incubation at room temperature, the plates were washed thrice with PBS and 
were incubated with 200 μL of 1% permeabilization solution (Triton X-100 in PBS) for 30 min at room tempera-
ture. Afterwards Triton X-100 was replaced with 200 μL of 2% blocking solution (10% BSA in PBS; KPL, 50-61-
01, Whitehead Scientific) and incubated for 2 h at room temperature. Plates were washed and incubated with 
100 μL of 1:30 diluted primary antibody (P53, Cat# SC-99, Santa Cruz biotechnology; Caspase 3, Cat# SC-7272, 
Santa Cruz biotechnology; Bax, Cat# 336400, Life technologies), for 2 h at room temperature. Plates were washed 
thrice with 1% wash buffer (400X Tween-20 in PBS) and 100 μL of a 1:5000 secondary antibody was added (Goat 
anti-mouse IgG-HRP: Cat# SC-2005, Santa Cruz Biotechnology) and incubated for 2 h at room temperature. 
Followed by rinsing, 100 μL TMB was added and the reaction was stopped by adding 1 M hydrochloric acid and 
the colorimetric reaction was measured at 450 nm (Perkin-Elmer, Victor3 plate reader).
Statistical analysis. All data were presented as mean ± standard error of the mean (SEM) of at least three 
tests done in duplicates. The statistical significance was analysed using Sigma Plot version 13.0. The treated groups 
were compared with the control groups by one way ANOVA to analyse the statistical significance. The p value less 
than 0.05 was measured as significant.
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Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding 
author on reasonable request.
References
 1. Jahangirian, H., Lemraski, E. G., Webster, T. J., Moghaddam, R. R. & Abdollahi, Y. A review of drug delivery systems based on 
nanotechnology and green chemistry: green nanomedicine. Int. J. Nanomed. 12, 2957–2978 (2017).
 2. Kumar, N., George, B. P. A., Abrahamse, H., Parashar, V. & Ngila, J. C. Sustainable one-step synthesis of hierarchical microspheres of 
PEGylated MoS2 nanosheets and MoO3 nanorods: Their cytotoxicity towards lung and breast cancer cells. Appl. Surf. Sci. 396, 8–18 
(2017).
 3. Katti, K. V. Renaissance of nuclear medicine through green nanotechnology: functionalized radioactive gold nanoparticles in cancer 
therapy- my journey, from chemistry to saving human lives. J. Radioanal. Nucl. Chem. 309, 5–14 (2016).
 4. Kumar, N. et al. A novel approach to low-temperature synthesis of cubic HfO2 nanostructures and their cytotoxicity. Sci. Rep. 7, 
9351 (2017).
 5. Hernandez-Sierra, J. F. et al. The antimicrobial sensitivity of Streptococcus mutansto nanoparticles of silver, zinc oxide, and gold. 
Nanomed. Nanotechnol. Biol. Med. 4, 237–240 (2008).
 6. Potgieter, K., Cronjé, M. J. & Meijboom, R. Synthesis of silver(I) p-substituted phenyl diphenyl phosphinecomplexes with the 
evaluation of the toxicity on a SNO cancer cell line. Inorg. Chim. Acta 453, 443–451 (2016).
 7. Kim, B. Y., Rutka, J. T. & Chan, W. C. Current concepts: Nanomedicine. N. Engl. J. Med. 363, 2434–2443 (2010).
 8. Irache, J. M., Esparza, I., Gamazo, C., Agüeros, M. & Espuelas, S. Nanomedicine: novel approaches in human and veterinary 
therapeutics. Vet. Parasitol. 180, 47–71 (2011).
 9. Sriram, M. I., Barath, S., Kanth, M., Kalishwaralal, K. & Gurunathan, S. Antitumor activity of silver nanoparticles in Dalton’s 
lymphoma ascites tumor model. Int. J. Nanomed. 5, 753–762 (2010).
 10. Venugopal, K. et al. Synthesis of silver nanoparticles (Ag NPs) for anticancer activities (MCF 7 breast and A549 lung cell lines) of the 
crude extract of Syzygium aromaticum. J. Photochem. Photobiol. B. 167, 282–289 (2017).
 11. Chen, X. & Schluesener, H. J. Nanosilver: a nanoproduct in medical application. Toxicol. Lett. 176, 1–12 (2008).
 12. Lok, C. N. et al. Proteomic analysis of the mode of antibacterial action of silver nanoparticles. J. Proteome. Res. 5, 916–24 (2006).
 13. Lim, B. & Xia, Y. Metal nanocrystals with highly branched morphologies. Angew. Chem. Int. Ed. 50, 76–85 (2011).
 14. Shankar, S. S., Rai, A., Ahmad, A. & Sastry, M. Rapid synthesis of Au, Ag, and bimetallic Au core–Ag shell nanoparticles using Neem 
(Azadirachta indica) leaf broth. J. Colloid Interface Sci. 275, 496–502 (2004).
 15. Parashar, U. K., Sexena, P. S. & Anchal, S. Bioinspired synthesis of silver nanoparticles. Dig. J. Nanomater. Biostruct. 4, 159–166 
(2009).
 16. Alam, M. N., Roy, N., Mandal, D. & Begum, N. A. Green chemistry for nanochemistry: exploring medicinal plants for the biogenic 
synthesis of metal NPs with fine-tuned properties. RSC Adv. 3, 11935–11956 (2013).
 17. George, B. P., Abrahamse, H. & Parimelazhagan T. Anticancer effects elicited by combination of Rubus extract with phthalocyanine 
photosensitiser on MCF-7 human breast cancer cells. Photodiagn. Photodyn. Ther. 19, 266–273 (2017).
 18. AshaRani, P. V., Mun, G. L. K., Hande, M. P. & Valiyaveetti, S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. 
ACS Nano 3, 279–290 (2009).
 19. Sanpui, P., Chattopadhyay, A. & Ghosh, S. S. Induction of apoptosis in cancer cells at low silver nanoparticle concentrations using 
chitosan nanocarrier. ACS Appl. Mater. Interfaces 3, 218–228 (2011).
 20. Nadagouda, M. N. et al. Synthesis of silver and gold nanoparticles using antioxidants from blackberry, blueberry, pomegranate, and 
turmeric extracts. ACS Sustainable Chem. Eng. 2, 1717–1723 (2014).
 21. Raveendran, P., Fu, J. & Wallen, S. L. Completely green synthesis and stabilization of metal nanoparticles. J. Am. Chem. Soc. 126, 
13940–13941 (2003).
 22. Ramalingam, B., Parandhaman, T. & Das, S. K. Antibacterial effects of biosynthesized silver nanoparticles on surface ultrastructure 
and nanomechanical properties of gram-negative bacteria viz. escherichia coli and pseudomonas aeruginosa. ACS Appl. Mater. 
Interfaces 8, 4963–4976 (2016).
 23. Kumar, A., Vyas, G., Bhatt, M., Bhatt, S. & Paul, P. Silver nanoparticle based highly selective and sensitive solvatochromatic sensor 
for colorimetric detection of 1, 4-Dioxane in aqueous media. Chem. Commun. 51, 15936–15939 (2015).
 24. Mangini, V. et al. Amyloid transition of ubiquitin on silver nanoparticles produced by pulsed laser ablation in liquid as a function of 
stabilizer and single-point mutations. Chem.-A Eur. J. 20, 10745–10751 (2014).
 25. Kreibig, U. & Vollumer, M. Optical properties of metal clusters. Springer, Berlin, 10.1007/978-3-662-09109-8 (1995).
 26. Shivakumara, M. et al. Biosynthesis of silver nanoparticles using pre-hydrolysis liquor of Eucalyptus wood and its effective 
antimicrobial activity. Enzyme Microb. Technol. 97, 55–62 (2017).
 27. Gao, J. et al. Formation and photoluminescence of silver nanoparticles stabilized by a two-armed polymer with a crown ether core. 
Langmuir 20, 9775–9779 (2004).
 28. Jia, K. et al. Facile synthesis of luminescent silver nanoparticles and fluorescence interactions with blue-emitting polyarylene ether 
nitrile. J. Mater. Chem. C. 3, 3522–3529 (2015).
 29. Kong, F. et al. Modulating emission from acceptor in donor-acceptor diblock copolymers by plasmon resonance energy transfer. J. 
Appl. Phys. 110, 114319 (2011).
 30. Kumar, N. et al. Morphogenesis of ZnO nanostructures: Role of acetate (COO-) and nitrate (NO3−) ligand donor from zinc salt 
precursors in synthesis and morphology dependent photo-catalytic properties. RSC Adv. 5, 38801–38809 (2015).
 31. Kumar, N., Reddy, L., Parashar, V. & Ngila, J. C. Controlled synthesis of microsheets of ZnAl layered double hydroxides hexagonal 
nanoplates for efficient removal of Cr(VI) ions and anionic dye from water. J. Environ. Chem. Eng. 5, 1718–1731 (2017).
 32. Cathcart, N. & Kitaev, V. Symmetry breaking by surface blocking: synthesis of bimorphic silver nanoparticles, nanoscale fishes and 
apples. Sci. Rep. 6, 32561 (2016).
 33. Morones, J. R. et al. The bactericidal effect of silver nanoparticles. Nanotechnol. 16, 2346–2353 (2005).
 34. Nayak, D., Pradhan, S., Ashe, S., Rauta, P. R. & Nayak, B. Biologically synthesised silver nanoparticles from three diverse family of 
plant extracts and their anticancer activity against epidermoid A431 carcinoma. J. Colloid Interface Sci. 457, 329–338 (2015).
 35. Gliga, A. R., Skoglund, S., Wallinder, I. O., Fadeel, B. & Karlsson, H. L. Size-dependent cytotoxicity of silver nanoparticles in human 
lung cells: the role of cellular uptake, agglomeration and Ag release. Part. Fibre Toxicol. 11, 11 (2014).
 36. Woźniak, A. et al. Size and shape-dependent cytotoxicity profile of gold nanoparticles for biomedical applications. J. Mater. Sci: 
Mater. Med. 28, 92 (2017).
 37. Oh, W. K. et al. Cellular uptake, cytotoxicity, and innate immune response of silica-titania hollow nanoparticles based on size and 
surface functionality. ACS Nano. 4, 5301–5313 (2010).
 38. Wang, C. & Suresh, V. Correlation of biocapping agents with cytotoxic effects of silver nanoparticles on human tumor cells. RSC Adv. 
3, 14329–14338 (2013).
 39. Hsin, Y. H. et al. The apoptotic effect of nanosilver is mediated by a ROS- and JNK-dependent mechanism involving the 
mitochondrial pathway in NIH3T3 cells. Toxicol. Lett. 179, 130–139 (2008).
www.nature.com/scientificreports/
1 4SCIenTIfIC RepoRts |  (2018) 8:14368  | DOI:10.1038/s41598-018-32480-5
 40. Jahani-Asl, A., Germain, M. & Slack, R. S. Mitochondria: Joining forces to thwart cell death. Biochim. Biophys. Acta, Mol. Basis Dis. 
1802, 162–166 (2010).
 41. Park, E. J. et al. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol. Lett. 
180, 222–229 (2008).
 42. Ozaki, T., Yamashita, T. & Ishiguro, S. I. Mitochondrial m-calpain plays a role in the release of truncated apoptosis-inducing factor 
from the mitochondria. Biochim. Biophys. Acta. 1793, 1848–1859 (2009).
 43. Chipuk, J. E. & Green, D. R. Do inducers of apoptosis trigger caspase-independent cell death. Nat. Rev. Mol. Cell Biol. 6, 268–275 
(2005).
 44. Ramar, M., Manikandan, B., Marimuthu, P. N. & Raman, T. Synthesis of silver nanoparticles using solanumtrilobatum fruits extract 
and its antibacterial, cytotoxic activity against human breast cancer cell line MCF 7. Spectrochim. Acta A Mol. Biomol. Spectrosc. 140, 
223–228 (2015).
 45. Green, D. R. & Reed, J. C. Mitochondria and apoptosis. Science 281, 1309–1312 (1998).
 46. Kroemer, G., Zamzami, N. & Susin, S. A. Mitochondrial control of apoptosis. Immunol. Today 8, 44–51 (1997).
 47. Jeyaraj, M. et al. An investigation on the cytotoxicity and caspase-mediated apoptotic effect of biologically synthesized silver 
nanoparticles using Podophyllumhexandrum on human cervical carcinoma cells. Colloids Surf. B 102, 708–717 (2013).
 48. Verbon, E. H., Post, J. A. & Boonstra, J. The influence of reactive oxygen species on cell cycle progression in mammalian cells. Gene 
511, 1–6 (2012).
 49. Dikalov, S. I. & Harrison, D. G. Methods for detection of mitochondrial and cellular reactive oxygen species. Antioxid. Redox Signal 
20, 372–382 (2014).
 50. Cryns, V. & Yuan, J. Proteases to die for. Genes Dev. 12, 1551–1570 (1998).
 51. Le Rhun, Y., Kirkland, J. & Shah, G. Cellular responses to DNA damage in the absence of Poly(ADP-ribose) polymerase. Biochem. 
Biophys. Res. Commun. 245, 1–10 (1998).
 52. Wu, Y. X., Da Liu, L. & Gao., B. Regulation of Bax activation and apoptotic response to UV irradiation by p53 transcription-
dependent and -independent pathways. Cancer Lett. 271, 231–239 (2008).
 53. Li, B. et al. Chaetoglobosin K induces apoptosis and G2 cell cycle arrest through p53-dependent pathway in cisplatin-resistant 
ovarian cancer cells. Cancer Lett. 356, 418–433 (2015).
 54. Adams, J. M. & Cory, S. Bcl-2-regulated apoptosis: mechanism and therapeutic potential. Curr. Opin. Immunol. 19, 488–496 (2007).
 55. Zhang, J., Huang, K., O’Neill, K. L., Pang, X. & Luo, X. Bax/Bak activation in the absence of Bid, Bim, Puma, and p53. Bax/Bak 
activation in the absence of Bid, Bim, Puma, and p53. Cell Death Dis. 7, e2266, https://doi.org/10.1038/cddis.2016.167 (2016).
Acknowledgements
This work is based on the research supported by the South African Research Chairs Initiative of the Department 
of Science and Technology and National Research Foundation of South Africa (Grant No 98337), as well as grants 
received from the University of Johannesburg (URC), the National Research Foundation (NRF), and the CSIR 
(Council for Scientific and industrial Research) – NLC (National Laser Centre) Laser Rental Pool Programme.
Author Contributions
Blassan P. George and Neeraj Kumar planned the project, performed all laboratory works, analysis, and wrote the 
manuscript. Heidi Abrahamse and Suprakas Sinha Ray coordinated, supervised this research work and reviewed 
the manuscript.
Additional Information
Supplementary information accompanies this paper at https://doi.org/10.1038/s41598-018-32480-5.
Competing Interests: The authors declare no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International 
License, which permits use, sharing, adaptation, distribution and reproduction in any medium or 
format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Cre-
ative Commons license, and indicate if changes were made. The images or other third party material in this 
article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the 
material. If material is not included in the article’s Creative Commons license and your intended use is not per-
mitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the 
copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
 
© The Author(s) 2018
